Solubility of the Metastable Polymorph of Piracetam (Form II) in a Range of Solvents
- 26 October 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Chemical & Engineering Data
- Vol. 57 (12), 3525-3531
- https://doi.org/10.1021/je300711r
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Solubility of Form III Piracetam in a Range of SolventsJournal of Chemical & Engineering Data, 2010
- Solvent Influences on Metastable Polymorph Lifetimes: Real-Time Interconversions Using Energy Dispersive X-Ray Diffractometry**We dedicate this paper to Professor David Grant. Not only a talented scientist, he was a man who gave freely of his time and ideas to support and encourage others, including ourselves.Journal of Pharmaceutical Sciences, 2007
- Piracetam: A Review of Pharmacological Properties and Clinical UsesCNS Drug Reviews, 2005
- Scientific considerations of pharmaceutical solid polymorphism in abbreviated new drug applications.Pharmaceutical Research, 2003
- Solubility of Phenylacetic Acid, p-Hydroxyphenylacetic Acid, p-Aminophenylacetic Acid, p-Hydroxybenzoic Acid, and Ibuprofen in Pure SolventsJournal of Chemical & Engineering Data, 2002
- The Cambridge Structural Database: a quarter of a million crystal structures and risingActa crystallographica Section B, Structural science, crystal engineering and materials, 2002
- Design and Study of Piracetam-like Nootropics, Controversial Members of the Problematic Class of Cognition-Enhancing DrugsCurrent Pharmaceutical Design, 2002
- Crystalline solidsAdvanced Drug Delivery Reviews, 2001
- Concomitant PolymorphsAngewandte Chemie, 1999
- The kinetics of solvent-mediated phase transformationsProceedings of the Royal Society of London. Series A - Mathematical and Physical Sciences, 1985